SLC2A2 and Insulin resistance: Although MASLD was not studied explicitly, topiramate treatment in rats with high-fat/high-fructose-induced insulin resistance resulted in increased liver expression of adiponectin receptors, GLUT2, and tyrosine kinase activity [16], thereby implicating pathways of glucose utilization and cell proliferation.